BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31197767)

  • 1. Mobilization and Collection of Peripheral Blood Stem Cells in Adults: Focus on Timing and Benchmarking.
    Kriegsmann K; Wuchter P
    Methods Mol Biol; 2019; 2017():41-58. PubMed ID: 31197767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection.
    Kriegsmann K; Schmitt A; Kriegsmann M; Bruckner T; Anyanwu A; Witzens-Harig M; Müller-Tidow C; Klein S; Wuchter P
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1281-1288. PubMed ID: 29353110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
    Lefrere F; Makke J; Fermand J; Marolleau J; Dal Cortivo L; Alberti C; Mouton V; Benbunan M; Miclea J
    Bone Marrow Transplant; 1999 Sep; 24(5):463-6. PubMed ID: 10482928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
    Blank N; Lisenko K; Pavel P; Bruckner T; Ho AD; Wuchter P
    Eur J Haematol; 2016 Jul; 97(1):78-82. PubMed ID: 26381040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients.
    Lisenko K; Wuchter P; Hansberg M; Mangatter A; Benner A; Ho AD; Goldschmidt H; Hegenbart U; Schönland S
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1870-1878. PubMed ID: 28754546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
    Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
    Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.
    van Oostrum A; Zwaginga JJ; Croockewit S; Overdevest J; Fechter M; Ruiterkamp B; Brand A; Netelenbos T
    J Clin Apher; 2017 Dec; 32(6):397-404. PubMed ID: 28139098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous peripheral blood stem cell transplantation using simplified procedures for collection and freezing.
    Hwang WL; Tsai CS; Jour JH; Kuo LH; Chang YM
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):529-35. PubMed ID: 10462830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.
    Sauer S; Hieke L; Brandt J; Müller-Tidow C; Schmitt A; Kauer J; Kriegsmann K
    Transfus Med Hemother; 2023 Oct; 50(5):382-395. PubMed ID: 37899996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
    Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate.
    Sakashita AM; Kondo AT; Yokoyama APH; Lira SMC; Bub CB; Souza AM; Cipolletta ANF; Alvarez KC; Hamerschlak N; Kutner JM; Chiattone CS
    J Clin Apher; 2018 Jun; 33(3):331-341. PubMed ID: 29350425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte-colony-stimulating factor: implications for yield of hematopoietic progenitor cell collections.
    Webb IJ; Eickhoff CE; Elias AD; Ayash LJ; Wheeler CA; Schwartz GN; Demetri GD; Anderson KC
    Transfusion; 1996 Feb; 36(2):160-7. PubMed ID: 8614968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
    Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
    J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of effectiveness and safety between different biosimilars of G-CSF in the mobilization of peripheral blood stem cells (PBSCs) for autologous transplantation (autologous peripheral blood stem cell transplantation, auto-PBSCT).
    Wicherska-Pawłowska K; Rybka J; Prajs I; Szmigiel K; Tyc J; Frączak E; Biedroń M; Kalicińska E; Szymczak D; Wróbel T
    J Clin Apher; 2020 Jan; 35(1):4-8. PubMed ID: 31663634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in beta-thalassemia patients: kinetics of mobilization and composition of apheresis product.
    Li K; Wong A; Li CK; Shing MM; Chik KW; Tsang KS; Lai H; Leung TF; Yuen PM
    Exp Hematol; 1999 Mar; 27(3):526-32. PubMed ID: 10089916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The administration of 10 microg/kg granulocyte colony-stimulating factor (G-CSF) alone results in a successful peripheral blood stem cell collection when previous mobilization with chemotherapy and hematopoietic growth factor failed.
    D'Hondt L; Emmons RV; André M; Guillaume T; Feyens AM; Canon JL; Humblet Y; Longueville J; Symann M
    Leuk Lymphoma; 1999 Jun; 34(1-2):105-9. PubMed ID: 10350337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor-induced mobilization of peripheral blood stem cells for autologous and allogeneic transplantation. Fukuoka Bone Marrow Transplantation Group.
    Harada M; Teshima T; Fujisaki T; Mizuno S; Miyamoto T; Takamatsu Y; Kubota A; Ohno Y; Kuroiwa M; Takenaka K; Eto T; Akashi K; Gondo H; Okamura T; Inaba S; Niho Y
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S115-9. PubMed ID: 8765430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.